HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

Journal of Experimental Medicine

Volumn 209, Issue 3, 2012, Pages 551-563

  Schiraldi, Milena ^a   Raucci, Angela ^b,c   Muñoz, Laura Martínez ^d   Livoti, Elsa ^a   Celona, Barbara ^c   Venereau, Emilie ^b   Apuzzo, Tiziana ^a   De Marchis, Francesco ^b   Pedotti, Mattia ^a   Bachi, Angela ^b   Thelen, Marcus ^a   Varani, Luca ^a   Mellado, Mario ^d   Proudfoot, Amanda ^e   Bianchi, Marco Emilio ^b,f   Uguccioni, Mariagrazia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c HMGBiotech Srl   (Italy)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e MERCK SERONO S A   (Switzerland)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL MIGRATION; CONFORMATIONAL TRANSITION; CYTOKINE RELEASE; IN VIVO STUDY; INFLAMMATORY CELL; MONONUCLEAR CELL; MUSCLE INJURY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TISSUE INJURY;

ANIMALS; BASE SEQUENCE; CALCIUM SIGNALING; CELL MOVEMENT; CHEMOKINE CXCL12; DNA, COMPLEMENTARY; FIBROBLASTS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, MOLECULAR; MONOCYTES; MULTIPROTEIN COMPLEXES; NIH 3T3 CELLS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECEPTORS, CXCR4; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TOLL-LIKE RECEPTORS; TRANSFECTION;

EID: 84860361435     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111739     Document Type: Article

References (50)

1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9: 143-150. http://dx.doi.org/10.1016/S1074-7613(00)80596-8
2. Agace, W.W., A. Amara, A.I. Roberts, J.L. Pablos, S. Thelen, M. Uguccioni, X.Y. Li, J. Marsal, F. Arenzana-Seisdedos, T. Delaunay, et al. 2000. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr. Biol. 10:325-328. http://dx.doi.org/10.1016/S0960-9822(00)00380-8
3. Andersson, U., and H.E. Harris. 2010. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim. Biophys. Acta. 1799:141-148.
4. Andrassy, M., H.C. Volz, J.C. Igwe, B. Funke, S.N. Eichberger, Z. Kaya, S. Buss, F. Autschbach, S.T. Pleger, I.K. Lukic, et al. 2008. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 117:3216-3226. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.769331
5. Apetoh, L., F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo, G. Mignot, M.C. Maiuri, E. Ullrich, P. Saulnier, et al. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13:1050-1059. http://dx.doi.org/10.1038/nm1622
6. Bianchi, M.E. 2009. HMGB1 loves company. J. Leukoc. Biol. 86:573-576. http://dx.doi.org/10.1189/jlb.1008585
7. Campana, L., L. Bosurgi, M.E. Bianchi, A.A. Manfredi, and P. Rovere-Querini. 2009. Requirement of HMGB1 for stromal cell-derived factor-1/ CXCL12-dependent migration of macrophages and dendritic cells. J. Leukoc. Biol. 86:609-615. http://dx.doi.org/10.1189/jlb.0908576
8. Chen, L.Y., and Z.K. Pan. 2009. Synergistic activation of leukocytes by bacterial chemoattractants: potential drug targets. Endocr. Metab. Immune Disord. Drug Targets. 9:361-370. http://www.ncbi.nlm.nih.gov/pubmed/19601917?dopt=Abstract
9. Clark-Lewis, I., L. Vo, P. Owen, and J. Anderson. 1997. Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol. 287:233-250. http://dx.doi.org/10.1016/S0076-6879(97)87018-8
10. Crump, M.P., J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. Arenzana-Seisdedos, J.L. Virelizier, M. Baggiolini, B.D. Sykes, and I. Clark-Lewis. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16:6996-7007. http://dx.doi.org/10.1093/emboj/16.23.6996
11. Degryse, B., T. Bonaldi, P. Scaffidi, S. Müller, M. Resnati, F. Sanvito, G. Arrigoni, and M.E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197-1206. http://dx.doi.org/10.1083/jcb.152.6.1197
12. DiPersio, J.F., G.L. Uy, U. Yasothan, and P. Kirkpatrick. 2009. Plerixafor. Nat. Rev. Drug Discov. 8:105-106. http://dx.doi.org/10.1038/nrd2819
13. Ditsworth, D., W.X. Zong, and C.B. Thompson. 2007. Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the proinflammatory mediator HMGB1 from the nucleus. J. Biol. Chem. 282:17845-17854. http://dx.doi.org/10.1074/jbc.M701465200
14. Ivanov, S., A.M. Dragoi, X. Wang, C. Dallacosta, J. Louten, G. Musco, G. Sitia, G.S. Yap, Y. Wan, C.A. Biron, et al. 2007. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood. 110:1970-1981. http://dx.doi.org/10.1182/blood-2006-09-044776
15. Jujo, K., H. Hamada, A. Iwakura, T. Thorne, H. Sekiguchi, T. Clarke, A. Ito, S. Misener, T. Tanaka, E. Klyachko, et al. 2010. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. USA. 107:11008-11013. http://dx.doi.org/10.1073/pnas.0914248107
16. Knapp, S., S. Müller, G. Digilio, T. Bonaldi, M.E. Bianchi, and G. Musco. 2004. The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry. 43:11992-11997. http://dx.doi.org/10.1021/bi049364k
17. Koenen, R.R., P. von Hundelshausen, I.V. Nesmelova, A. Zernecke, E.A. Liehn, A. Sarabi, B.K. Kramp, A.M. Piccinini, S.R. Paludan, M.A. Kowalska, et al. 2009. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15:97-103. http://dx.doi.org/10.1038/nm.1898
18. Levoye, A., K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane. 2009. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 113:6085-6093. http://dx.doi.org/10.1182/blood-2008-12-196618
19. Liliensiek, B., M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H.J. Gröne, F.C. Kurschus, A.M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113:1641-1650.
20. Livesey, K.M., D. Tang, H.J. Zeh, and M.T. Lotze. 2009. Autophagy inhibition in combination cancer treatment. Curr. Opin. Investig. Drugs. 10:1269-1279.
21. Loetscher, M., T. Geiser, T. O'Reilly, R. Zwahlen, M. Baggiolini, and B. Moser. 1994. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269:232-237.
22. Lotze, M.T., and K.J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-342. http://dx.doi.org/10.1038/nri1594
23. Maroso, M., S. Balosso, T. Ravizza, J. Liu, E. Aronica, A.M. Iyer, C. Rossetti, M. Molteni, M. Casalgrandi, A.A. Manfredi, et al. 2010. Tolllike receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16:413-419. http://dx.doi.org/10.1038/nm.2127
24. Martínez Muñoz, L., P. Lucas, G. Navarro, A.I. Checa, R. Franco, C. Martínez-A, J.M. Rodríguez-Frade, and M. Mellado. 2009. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J. Immunol. 183:7337-7346. http://dx.doi.org/10.4049/jimmunol.0901802
25. Mollica, L., F. De Marchis, A. Spitaleri, C. Dallacosta, D. Pennacchini, M. Zamai, A. Agresti, L. Trisciuoglio, G. Musco, and M.E. Bianchi. 2007. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol. 14:431-441. http://dx.doi.org/10.1016/j.chembiol.2007.03.007
26. Murphy, P.M. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54:227-229. http://dx.doi.org/10.1124/pr.54.2.227
27. Orlova, V.V., E.Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C.M. Ballantyne, C.G. Gahmberg, M.E. Bianchi, P.P. Nawroth, and T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26:1129-1139. http://dx.doi.org/10.1038/sj.emboj.7601552
28. Palumbo, R., F. De Marchis, T. Pusterla, A. Conti, M. Alessio, and M.E. Bianchi. 2009. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J. Leukoc. Biol. 86:617-623. http://dx.doi.org/10.1189/jlb.0908581
29. Paoletti, S., V. Petkovic, S. Sebastiani, M.G. Danelon, M. Uguccioni, and B.O. Gerber. 2005. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood. 105:3405-3412. http://dx.doi.org/10.1182/blood-2004-04-1648
30. Penzo, M., R. Molteni, T. Suda, S. Samaniego, A. Raucci, D.M. Habiel, F. Miller, H.P. Jiang, J. Li, R. Pardi, et al. 2010. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]. J. Immunol. 184:4497-4509. http://dx.doi.org/10.4049/jimmunol.0903131
31. Percherancier, Y., Y.A. Berchiche, I. Slight, R. Volkmer-Engert, H. Tamamura, N. Fujii, M. Bouvier, and N. Heveker. 2005. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280:9895-9903. http://dx.doi.org/10.1074/jbc.M411151200
32. Proudfoot, A.E., and F. Borlat. 2000. Purification of recombinant chemokines from E. coli. Methods Mol. Biol. 138:75-87.
33. Sha, Y., J. Zmijewski, Z. Xu, and E. Abraham. 2008. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180:2531-2537.
34. Sitia, G., M. Iannacone, S. Müller, M.E. Bianchi, and L.G. Guidotti. 2007. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukoc. Biol. 81:100-107. http://dx.doi.org/10.1189/jlb.0306173
35. Sitia, G., M. Iannacone, R. Aiolfi, M. Isogawa, N. van Rooijen, C. Scozzesi, M.E. Bianchi, U.H. von Andrian, F.V. Chisari, and L.G. Guidotti. 2011. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 7:e1002061. http://dx.doi.org/10.1371/journal.ppat.1002061
36. Skinner, M. 2010. Autophagy: in the hands of HMGB1. Nat. Rev. Mol. Cell Biol. 11:756-757. http://dx.doi.org/10.1038/nrm2994
37. Tang, D., R. Kang, K.M. Livesey, C.W. Cheh, A. Farkas, P. Loughran, G. Hoppe, M.E. Bianchi, K.J. Tracey, H.J. Zeh III, and M.T. Lotze. 2010. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190:881-892. http://dx.doi.org/10.1083/jcb.200911078
38. Tian, J., A.M. Avalos, S.Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, et al. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487-496. http://dx.doi.org/10.1038/ni1457
39. Tsung, A., J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, X. Peng, D.B. Stolz, D.A. Geller, M.R. Rosengart, and T.R. Billiar. 2007. HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204:2913-2923. http://dx.doi.org/10.1084/jem.20070247
40. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 α and MIP-1 β on human monocytes. Eur. J. Immunol. 25:64-68. http://dx.doi.org/10.1002/eji.1830250113
41. Varani, L., A.J. Bankovich, C.W. Liu, L.A. Colf, L.L. Jones, D.M. Kranz, J.D. Puglisi, and K.C. Garcia. 2007. Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc. Natl. Acad. Sci. USA. 104: 13080-13085. http://dx.doi.org/10.1073/pnas.0703702104
42. Venetz, D., M. Ponzoni, M. Schiraldi, A.J. Ferreri, F. Bertoni, C. Doglioni, and M. Uguccioni. 2010. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int. J. Cancer. 127:2300-2312. http://dx.doi.org/10.1002/ijc.25236
43. von Hundelshausen, P., R.R. Koenen, M. Sack, S.F. Mause, W. Adriaens, A.E. Proudfoot, T.M. Hackeng, and C. Weber. 2005. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 105:924-930. http://dx.doi.org/10.1182/blood-2004-06-2475
44. Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248-251. http://dx.doi.org/10.1126/science.285.5425.248
45. Wu, B., E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P. Wells, F.C. Bi, et al. 2010. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 330:1066-1071. http://dx.doi.org/10.1126/science.1194396
46. Yang, D., Q. Chen, H. Yang, K.J. Tracey, M. Bustin, and J.J. Oppenheim. 2007. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81:59-66. http://dx.doi.org/10.1189/jlb.0306180
47. Yang, H., H.S. Hreggvidsdottir, K. Palmblad, H. Wang, M. Ochani, J. Li, B. Lu, S. Chavan, M. Rosas-Ballina, Y. Al-Abed, et al. 2010. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA. 107:11942-11947. http://dx.doi.org/10.1073/pnas.1003893107
48. Yang, H., P. Lundbäck, L. Ottosson, H. Erlandsson-Harris, E. Venereau, M.E. Bianchi, Y. Al-Abed, U. Andersson, K.J. Tracey, and D.J. Antoine. 2012. Redox modification of cysteine residues regulates the cytokine activity of HMGB1. Mol. Med. doi:10.2119/molmed.2011.00389.
49. Zimmermann, T., J. Rietdorf, A. Girod, V. Georget, and R. Pepperkok. 2002. Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair. FEBS Lett. 531:245-249. http://dx.doi.org/10.1016/S0014-5793(02)03508-1
50. Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595-599. http://dx.doi.org/10.1038/31269